Page last updated: 2024-08-23

ilmofosine and Carcinoma 256, Walker

ilmofosine has been researched along with Carcinoma 256, Walker in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Grunicke, H; Herrmann, DB; Hofmann, J; Maly, K; Posch, L; Ueberall, F	1

Other Studies

1 other study(ies) available for ilmofosine and Carcinoma 256, Walker

Article	Year
Synergistic enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by the ether lipid analogue BM41440, an inhibitor of protein kinase C. Lipids, 1989, Volume: 24, Issue:4 Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cell Division; Cisplatin; Drug Synergism; Phospholipid Ethers; Phosphorylation; Protein Kinase C; Rats; Ribosomal Protein S6; Ribosomal Proteins; Tumor Cells, Cultured	1989

Article

Year

Synergistic enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by the ether lipid analogue BM41440, an inhibitor of protein kinase C.

Lipids, 1989, Volume: 24, Issue:4

Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cell Division; Cisplatin; Drug Synergism; Phospholipid Ethers; Phosphorylation; Protein Kinase C; Rats; Ribosomal Protein S6; Ribosomal Proteins; Tumor Cells, Cultured

1989